Kyung Dong Pharmaceutical Co. Ltd (011040) — Capital Reinvestment Ratio
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Capital Reinvestment Ratio of 4.27x as of December 2025, meaning it reinvests 4% of its operating cash flow (₩2.45 Billion) in capital expenditures (₩10.48 Billion). See Kyung Dong Pharmaceutical Co. Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kyung Dong Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2011–2025)
This chart tracks Kyung Dong Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Check Kyung Dong Pharmaceutical Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Year-by-year Capital Reinvestment Ratio for Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. For live market cap and broader valuation context, see how much is Kyung Dong Pharmaceutical Co. Ltd worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.21x | ₩16.93 Billion | ₩20.51 Billion | ▲ +283.3% |
| 2021 | 0.32x | ₩12.42 Billion | ₩3.93 Billion | ▼ -81.1% |
| 2020 | 1.67x | ₩17.12 Billion | ₩28.59 Billion | ▲ +1313.5% |
| 2018 | 0.12x | ₩33.27 Billion | ₩3.93 Billion | ▼ -69.6% |
| 2017 | 0.39x | ₩14.79 Billion | ₩5.74 Billion | ▲ +38.3% |
| 2016 | 0.28x | ₩25.63 Billion | ₩7.19 Billion | ▼ -53.8% |
| 2015 | 0.61x | ₩18.26 Billion | ₩11.10 Billion | ▼ -34.8% |
| 2014 | 0.93x | ₩22.73 Billion | ₩21.17 Billion | ▲ +63.0% |
| 2013 | 0.57x | ₩16.42 Billion | ₩9.38 Billion | ▲ +61.4% |
| 2012 | 0.35x | ₩19.96 Billion | ₩7.06 Billion | ▲ +277.9% |
| 2011 | 0.09x | ₩26.08 Billion | ₩2.44 Billion | — |